Global Single Photon Emission Computed Tomography (SPECT) Market Research Report 2021 - ResearchAndMarkets.com
Retrieved on:
Thursday, July 1, 2021
Technology, Medical devices, Other Technology, Cardiology, Radiology, Health, Pharmaceutical, General Health, Oncology, Neuroimaging, Medicine, Clinical medicine, Branches of biology, Radiobiology, Medical imaging, Emission computed tomography, Tomography, Single-photon, Advanced Cyclotron Systems, Draft:MILabs
The "Single Photon Emission Computed Tomography (SPECT) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Key Points:
- The "Single Photon Emission Computed Tomography (SPECT) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
- Amid the COVID-19 crisis, the global market for Single Photon Emission Computed Tomography (SPECT) estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at a CAGR of 6.8% over the period 2020-2027.
- This segment currently accounts for a 43.8% share of the global Single Photon Emission Computed Tomography (SPECT) market.
- The U.S. Accounts for Over 36.1% of Global Market Size in 2020, While China is Forecast to Grow at a 9.4% CAGR for the Period of 2020-2027
The Single Photon Emission Computed Tomography (SPECT) market in the U.S. is estimated at US$608.4 Million in the year 2020.